The antiresorptive effects of a single dose of zoledronate persist for two years: a randomized, placebo-controlled trial in osteopenic postmenopausal women (Q46218698)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The antiresorptive effects of a single dose of zoledronate persist for two years: a randomized, placebo-controlled trial in osteopenic postmenopausal women |
scientific article |
Statements
1 reference
The antiresorptive effects of a single dose of zoledronate persist for two years: a randomized, placebo-controlled trial in osteopenic postmenopausal women (English)
1 reference
1 reference
1 reference
Greg Gamble
1 reference
Andrew Grey
1 reference
Diana Wattie
1 reference
2 December 2008
1 reference
94
1 reference
2
1 reference
538-544
1 reference
Identifiers
1 reference
1 reference